(Q36828565)

16 August 2017

1 reference

title

Treatment of chronic hepatitis C with alpha-interferon (English)

1 reference

16 August 2017

1 reference

G. C. Farrell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751801

16 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1751801

16 November 2022

publication date

1 January 1991

1 reference

full work available at URL

16 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.1991.tb01166.x

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.1991.tb01166.x/fullpdf

16 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Journal of Gastroenterology and Hepatology

16 November 2022

published in

1 reference

16 August 2017

volume

6 Suppl 1

1 reference

16 August 2017

page(s)

36-40

1 reference

Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01166.X

Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01166.X

Recombinant alpha-interferon treatment of non-A, and non-B (type C) hepatitis: review of studies and recommendations for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01166.X

An economic evaluation of the costs of alpha-interferon treatment of chronic active hepatitis due to hepatitis B or C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01166.X

Treatment of chronic non-A, non-B hepatitis wih acyclovir: pilot study

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

16 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

16 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

16 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

16 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?

16 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b

16 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis

16 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

16 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

Recombinant human γ-interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects

16 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB01166.X

16 November 2022

Identifiers

1 reference

16 August 2017

1 reference